Targeting insulin receptor in estrogen receptor positive breast cancer

被引：0
|
作者：
Cao, Jingran
Fettig, Lynsey M.
LaPara, Kelly
Zhang, Xihong
Murikipudi, Sylaja
Delpero, Andrea R.
Lancaster, Thomas M.
Zion, Todd C.
Yee, Douglas
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P4-02-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-02-01
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
    Datta, Jharna
    Willingham, Natalie
    Manouchehri, Jasmine M.
    Schnell, Patrick
    Sheth, Mirisha
    David, Joel J.
    Kassem, Mahmoud
    Wilson, Tyler A.
    Radomska, Hanna S.
    Coss, Christopher C.
    Bennett, Chad E.
    Ganju, Ramesh K.
    Sardesai, Sagar D.
    Lustberg, Maryam
    Ramaswamy, Bhuvaneswari
    Stover, Daniel G.
    Cherian, Mathew A.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Estrogen receptor gene fusions drive endocrine therapy resistance in estrogen receptor positive breast cancer
    Lei, Jonathan T.
    Shao, Jieya
    Zhang, Jin
    Iglesia, Michael
    Chan, Doug W.
    Matsunuma, Ryoichi
    He, Xiaping
    Singh, Purba
    Kosaka, Yoshimasa
    Crowder, Robert
    Haricharan, Svasti
    Kavuri, Shyam
    Hoog, Jeremy
    Phommaly, Chanpheng
    Goncalves, Rodrigo
    Romalho, Susana
    Lai, Wei-Chu
    Hampton, Oliver
    Rogers, Anna
    Tobias, Ethan
    Parikh, Poojan
    Davies, Sherri
    Ma, Cynthia
    Suman, Vera
    Hunt, Kelly
    Watson, Mark
    Hoadley, Katherine A.
    Thompson, Aubrey
    Perou, Charles
    Creighton, Chad J.
    Maher, Chris
    Ellis, Matthew J.
    CANCER RESEARCH, 2017, 77
  • [33] Characterization of estrogen receptor-low-positive breast cancer
    Fei Fei
    Gene P. Siegal
    Shi Wei
    Breast Cancer Research and Treatment, 2021, 188 : 225 - 235
  • [34] Characterization of estrogen receptor-low-positive breast cancer
    Fei, Fei
    Siegal, Gene P.
    Wei, Shi
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (01) : 225 - 235
  • [35] Geographic excess of estrogen receptor-positive breast cancer
    Benz, CC
    Clarke, CA
    Moore, DH
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (12) : 1523 - 1527
  • [36] Estrogen receptor-positive breast cancer: a multidisciplinary challenge
    Zwart, Wilbert
    Theodorou, Vasiliki
    Carroll, Jason S.
    WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2011, 3 (02) : 216 - 230
  • [37] Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer
    Zhang, Xiang H. -F.
    Giuliano, Mario
    Trivedi, Meghana V.
    Schiff, Rachel
    Osborne, C. Kent
    CLINICAL CANCER RESEARCH, 2013, 19 (23) : 6389 - 6397
  • [38] Risk factors for estrogen receptor-positive breast cancer
    Hwang, ES
    Chew, T
    Shiboski, S
    Farren, G
    Benz, CC
    Wrensch, M
    ARCHIVES OF SURGERY, 2005, 140 (01) : 58 - 62
  • [39] The role of microRNAs in estrogen receptor α-positive human breast cancer
    Yamashita, Hiroko
    ENDOCRINE JOURNAL, 2010, 57 : S321 - S321
  • [40] Quantitative regression of estrogen receptor alpha positive breast cancer
    Boudreau, Matthew W.
    Hergenrother, Paul J.
    Duraki, Darjan
    Wang, Lawrence
    Mao, Chengjian
    Park, Ben H.
    Fan, Tim M.
    Nelson, Eric R.
    Shapiro, David J.
    Moreno, Ramon
    Bruckheimer, Elizabeth
    Kiefer, Jeffrey
    Tarasow, Theodore M.
    CANCER RESEARCH, 2020, 80 (04)
12345